Companies / Emergent BioSolutions Inc
Emergent BioSolutions Inc
NYSE: EBSCIK 1367644GAITHERSBURG, MD
Financials · FY2025
Ownership
51.3M shares outstanding · as of Jul 30, 2026
Ownership
| Insiders | 5.35% | 2,744,685 |
| 10%+ / strategic | 17.27% | 8,855,464 |
| Institutions | 71.94% | 36,887,350 |
| Public float | 5.43% | 2,785,837 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 16
View all →| Insider | % of shares | Shares |
|---|---|---|
Papa Joseph CCEOPresident and CEO · Director | 0.96% | 493,153 |
Lindahl Richard SEVP, Chief Financial Officer | 0.73% | 374,083 |
Glessner ColeenEVP, Quality & Ethics, and CPL | 0.39% | 202,201 |
Hartzel WilliamSVP, Bioservices | 0.36% | 185,558 |
Lowry Simon CSVP, R&D, CMO | 0.35% | 177,914 |
Perl JessicaSVP, General Counsel, Corp Sec | 0.32% | 165,286 |
Williams Paul AnthonySVP, Products Business | 0.32% | 162,098 |
Fowler Neal FranklinDirector | 0.31% | 160,847 |
Harsanyi ZsoltChairman · Director | 0.29% | 149,076 |
DeGolyer Donald WDirector | 0.25% | 129,721 |
Institutional holders 186
View all →| Holder | Value | % of shares |
|---|---|---|
| $43.93M | 6.93% | |
| $39.53M | 9.20% | |
| $30.15M | 4.76% | |
| $27.84M | 4.39% | |
| $24.56M | 5.71% | |
| $20.01M | 3.16% | |
| $14.31M | 2.26% | |
| $11.65M | 1.84% | |
| $10.57M | 2.48% | |
| $9.97M | 2.34% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Lindahl Richard S Executive | Other | Common Stock | $504.0K | -46K -15.83% | 245,342 0.48% of shares | low |
| Feb 6, 2026 | Glessner Coleen Executive | Other | Common Stock | $315.0K | -29K -19.99% | 115,472 0.23% of shares | low |
| Mar 5, 2026 | Papa Joseph C CEO | Other | Common Stock | $312.7K | -37K -10.82% | 305,445 0.60% of shares | low |
| Mar 5, 2026 | Lindahl Richard S Executive | Other | Common Stock | $199.6K | -24K -9.89% | 215,367 0.42% of shares | low |
| May 1, 2026 | Zoon Kathryn C Director | Sell | Common Stock | $135.0K | -16K -16.62% | 80,998 0.16% of shares | medium |
| Apr 30, 2026 | Katkin Keith Director | Sell | Common Stock | $128.2K | -15K -13.85% | 96,294 0.19% of shares | medium |
| May 1, 2026 | DeGolyer Donald W Director | Sell | Common Stock | $121.4K | -15K -10.00% | 130,675 0.25% of shares | medium |
| May 1, 2026 | Dayal Sujata Tyagi Director | Sell | Common Stock | $106.8K | -13K -11.18% | 101,543 0.20% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
| State Street Corporation | Passive13G | — |
| Dimensional Fund Advisors LP | Passive13G | — |
| Vanguard Capital Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EBS | — | 29089Q105 |